285
Participants
Start Date
November 30, 2004
Primary Completion Date
December 31, 2016
Study Completion Date
December 31, 2016
docetaxel
75 mg/m2 on day 1 (induction phase); 25 mg/m2 on day 1 (chemoradiotherapy phase)
cisplatin
75 mg/m2 on day 1
hydroxyurea
Each cycle: 500 mg PO q 12 hours x 6 days (11 doses)
fluorouracil
750 mg/m2/day on days 1-5 (induction phase); 600 mg/m2/day, day 0-4 (chemoradiotherapy phase)
chemotherapy
See protocol for details
radiotherapy
See protocol for details
Clinic of Oncology, University Hospital Center Zagreb, Zagreb
University Hospital for Tumors Zagreb, Zagreb
Fox Chase Cancer Center, Philadelphia
Clinique Armoricaine de Radiologie, Saint-Brieuc
Hospital Clínico San Carlos, Madrid
UM Sylvester Comprehensive Cancer Center, Miami
University of Tennessee Cancer Institute, Memphis
Fort Wayne Medical Oncology/Hematology Inc., Fort Wayne
AP&S Clinic, LLC, Terre Haute
Henry Ford Health System, Detroit
Oncology Care Associates PLLC, Saint Joseph
Oncology Alliance, Milwaukee
University of Minnesota, Minneapolis
Roger Maris Cancer Center, Fargo
Evanston Northwestern Healthcare, Evanston
Joliet Oncology Hematology Associates, Joliet
Northwestern University, Chicago
Rush University Medical Center, Chicago
The University of Chicago, Chicago
Weiss Memorial Hospital, Chicago
Kansas City VA Medical Center, Kansas City
University of Kansas Cancer Center, Kansas City
UT Health Science Center at San Antonio, San Antonio
USC University of Southern California Keck School of Medicine, Los Angeles
NN Blokhin Russian Cancer Research Centre RAMS, Moscow
Republican Oncology Dispensary, Ufa
University of Chicago
OTHER